Gottlieb: Investment into leveraging RWD will benefit device, drug safety

Gottlieb: Investment into leveraging RWD will benefit device, drug safety

Source: 
Biopharma Dive
snippet: 

FDA Commissioner Scott Gottlieb Tuesday laid out the agency’s plan to build a new $100 million medical data system that aims to better use real world data (RWD) collected from electronic health records to evaluate the safety of medical products after they hit the market.